Production responses to bovine somatotropin in northeast dairy herds

The commercial response to bovine somatotropin was examined in northeast dairy herds from 1990 to 1998 (4-yr preapproval and 4-yr postapproval). With DHI records and Monsanto customer files, a control group (never purchased Posilac) and a bovine somatotropin (bST) group (used on at least 50% of cows) were identified. A total of 340 herds were involved and, over the 8-yr period, there were over 80,000 cows, 200,000 lactations, and 2 million test days. Herd management comparisons demonstrated the response to bST was relatively constant each year of the postapproval period. Assuming 100% of cows were supplemented, response to bST over a 305-d lactation equaled 894 kg of milk, 27 kg of milk fat, and 31 kg of milk protein. Comparisons of lactation curves were used to identify where the bST response occurred in the lactation cycle. Analysis demonstrated the responses in milk, milk fat, and protein yield were minimal in the early phase of lactation, and then gradually increased until reaching a plateau over the last half of the lactation cycle. Persistency of lactation was also improved by bST, indicating the opportunity exists to extend lactation with combined use of bST and altered reproductive management. Average age and days in milk did not differ between control and bST herds. Thus, stayability and herd-life of animals were not altered by bST treatment. Somatic cell count (SCC) linear scores were minimally affected in herds utilizing bST and the pattern of SCC over the lactation cycle was unaffected. Overall bST improved lactation yield and persistency consistently over the 4-yr postapproval period with no effects on cow stayability and herd-life.     

Low doses of bovine somatotropin during the transition period and early lactation improves milk yield, efficiency of production, and other physiological responses of Holstein cows

The objectives of this experiment were to determine whether low doses of bovine somatotropin (bST) during the transition period and early lactation period improved dry matter intake (DMI), body weight (BW), or body condition score (BCS); provoked positive changes in concentrations of somatotropin, insulin, insulin-like growth factor-I (IGF-I), glucose, nonesterified fatty acids, and Ca; or improved milk yield (MY) response without obvious adverse effects on health status. Eighty-four multiparous Holstein cows completed treatments arranged in a 2 x 3 x 2 factorial design that included prepartum and postpartum bST, dry period (30 d dry, 30 d dry + estradiol cypionate, and 60 d dry), and prepartum anionic or cationic diets. Biweekly injections of bST began at 21 +/- 3 d before expected calving date through 42 +/- 2 d postpartum (control = 0 vs. bST = 10.2 mg of bST/d; POSILAC). At 56 +/- 2 d in milk, all cows were injected with a full dose of bST (500 mg of bST/14 d; POSILAC). During the prepartum period and during the first 28 d postpartum, no differences in mean BW, BCS, or DMI were detected between the bST treatment group and the control group. During the first 10 wk of lactation, cows in the bST treatment group had greater mean MY and 3.5% fat-corrected milk yield and lower SCC than did cows in the control group. When cows received a full dose of bST, an increase in milk production through wk 21 was maintained better by cows in the bST group. Mean concentrations of somatotropin, IGF-I, and insulin differed during the overall prepartum period (d -21 to -1). During the postpartum period (d 1 to 28), cows in the bST group had greater mean concentrations of somatotropin and IGF-I in plasma. Concentrations of Ca around calving did not differ because of bST treatment. Results suggest that changes in concentrations of blood measures provoked by injections of bST during the transition period and early lactation period resulted in improved metabolic status and production of the cows without apparent positive or negative effects on calving or health.     

Dose response to recombinant bovine somatotropin from weeks 15 to 44 postpartum in lactating dairy cows

Forty Holstein cows were used in an experiment to determine the response of cows to daily subcutaneous injections of 0, 10.3, 20.6, and 30.9 mg of recombinant bST. Injections began between 98 and 104 d postpartum and continued for 29 wk, up to 70 d prepartum, or a maximum of 400 d postpartum. Increasing recombinant bST increased milk yield and 3.5% FCM yield in a linear fashion and by 5.2 and 5.7 kg/d, respectively. Milk composition was not changed, and DM intake as a percentage of BW increased from 3.39 to 3.80% with increasing (30.9 mg/d) bST. Feed efficiency (3.5% FCM/DM intake) was increased from 1.35 to 1.64 with increasing dose, suggesting improved efficiency of use of DM intake, primarily by dilution of maintenance. Increasing bST reduced BW gain linearly from .46 kg/d for the control to .22 kg/d for the 30.9 mg/d bST. Calf birth weight, weight of cows at calving, and incidence of metabolic diseases during subsequent calving were not affected by bST. Somatotropin treatment resulted in somewhat smaller increased in milk yield than that reported in previous studies. Long-term health effects and effects on reproduction could not be determined from the relatively few cows used in this study.     

Investigation of factors affecting voluntary and involuntary culling in expanding dairy herds in Wisconsin using survival analysis

Trends in the relative risk of voluntary culling of low-producing cows and involuntary culling of high-producing cows were examined in 186 Wisconsin dairy herds that expanded significantly between 1994 and 1998. A Weibull model for survival analysis was applied to data of 72,456 Holstein cows with first calving from 1981 to 2000; this model included a time-independent effect of age at first calving and time-dependent effects of year-season, age-parity, and within herd-year quintile for combined fat + protein yield (by time period). The relative risk of (involuntary) culling of high-producing cows (versus average cows) increased from 0.5 in 1981 to 1989 to 0.68 in 1996 to 2000. Meanwhile, the relative risk of (voluntary) culling of low-producing cows decreased from 4.20 to 2.55 over the same time period. Variables related to facilities, labor, and management were obtained via survey, and the relative risk of culling for high-and low-producing cows after expansion (1996 to 2000) was calculated for different levels of each variable. Herds with fewer cows per employee and a greater percentage of labor supplied by family members tended to have lower risk of involuntary culling of profitable cows. Likewise, high-producing cows in herds with fans, sprinklers, self-locking manger stalls, palpation rails, and maternity pens had a significantly lower risk of culling than cows in herds without such facilities. Herds that used 100% artificial insemination (AI) had lower risk of involuntary culling than non-AI herds or herds with a cleanup bull, but 3x milking and use of a custom heifer grower led to unfavorable trends in involuntary culling. In summary, this study documented the unfavorable trends in voluntary and involuntary culling in expanding herds and quantified the gains producers can expect in cow survival by investing in improvements in facilities, labor, and management.     

Dynamics of culling risk with disposal codes reported by Dairy Herd Improvement dairy herds

The objective was to describe the dynamics of culling risk with disposal codes for Holstein dairy cows reported by herds enrolled in the Dairy Herd Improvement program. Dairy producers could report 1 of 9 possible disposal codes or forego reporting a code. After edits, 3,629,002 lactation records were available for cows calving between 2001 and 2006 in 2,054 herds located in 38 states primarily east of the Mississippi river. The distribution of culled cows by disposal code was estimated by parity, days after calving, pregnancy status, cow-relative 305-d mature equivalent milk yield, herd-relative 305-d mature equivalent milk yield, and season. Of all herds, 57% reported all 8 different disposal codes excluding the codes dairy purposes and reason not reported. Hazard (risk) functions were calculated by parity, from 1 to 520 d since calving for open cows and from 1 to 280 d since conception for pregnant cows. Annualized live culling rate and death rate (reported code was death) were 25.1 and 6.6%, respectively. The primary disposal code was died (20.6% of all culling), followed by reproduction (17.7%), injury/other (14.3%), and low production and mastitis (both 12.1%). The risk of culling with various disposal codes varied with stage of lactation. Died and reproduction were the most frequently reported codes for cows leaving the herd during early and late lactation, respectively. Early lactation was also a critical period for culling with the disposal codes injury/other and disease, and the risk increased with days after calving for the codes low production and reproduction. The risk of culling with the disposal code died showed the greatest seasonal pattern with increased risk of death in spring and summer. A negative association was found between annualized live culling and death rates within herds. Compared with open cows, pregnant cows had a lower risk of culling with all reported disposal codes. In addition, the risk of culling was lower in high-producing cows with all disposal codes. In conclusion, the risk for culling by disposal code varied by parity, stage of lactation, season, pregnancy status, and milk yield.     

Effect of dietary energy and previous bovine somatotropin on milk yield, mastitis, and reproduction in dairy cows.

Thirty multiparous lactating Holstein cows were blocked according to time of calving and assigned to a 2 x 3 factorial arrangement of treatments in a randomized complete block design to evaluate the effects of two dietary energy concentrations either without or with bST (20.6 mg/d per cow) administered to cows that had not or had received bST during the preceding lactation. Subcutaneous injection of bST began 28 to 35 d postpartum and continued for 39 wk. The dietary energy concentration x bST interaction was not significant for any response variable. Compared with DMI of control cows, DMI was higher for cows receiving bST, being 1.6 and 2.4 kg/d higher for cows receiving bST for one and two lactations, respectively. Milk, fat, and protein yields were higher for cows receiving bST than for controls. Those receiving bST for a second lactation also produced more milk than controls until wk 20; thereafter, milk yields were similar to those of controls. Somatotropin administration had no adverse effect on udder health. Cows receiving bST tended to ovulate less regularly than controls, which may be attributed to their higher milk yield. However, BW gains during lactation were similar for all treatments, indicating that bST-treated cows built energy reserves for the subsequent lactation. Although energy concentrations of the diets had no significant impact on yield, the higher energy diet tended to depress milk fat concentration. Administration of bST to dairy cows for a second, consecutive lactation yielded responses similar for the first 20 wk of the study to those receiving bST for the first time. However, after wk 20, milk yield was less than that by cows receiving bST for the first lactation but similar to that of control cows.     

Evaluation of sometribove in a prolonged-release system in lactating dairy cows--production responses

Primiparous (n = 105) and multiparous (n = 136) Holstein cows were used to evaluate efficacy of sometribove (n-methionyl bovine somatotropin, bST) in a dose titration study. Cows were fed TMR for ad libitum intake, were milked twice daily, and were allocated randomly within parity (1 vs. 2+) to treatments of 0, 250, 500, or 750 mg bST/14 d in a prolonged-release formulation. Subcutaneous injections commenced 60 +/- 3 d postpartum and continued throughout lactation. During a standardized treatment period of 252 d, treatment with increasing dosages of bST increased 3.5% FCM yield in a dose-dependent manner for both primiparous (2.5 kg/d, 10.2%; 3.5 kg/d, 14.3%; and 5.9 kg/d, 24.1%) and multiparous cows (3.1 kg/d, 12.1%; 3.9 kg/d, 15.2%; and 6.8 kg/d, 26.5%). Milk content of fat, protein, lactose, ash, Ca and P, and SCC were not affected by treatment. Over the 252-d treatment period, voluntary intake of energy was increased in bST-treated cows such that BW gain, body condition score, and net energy balance did not differ among treatment groups. Productive efficiency (milk per unit NEL intake corrected for BW change) over the treatment period was significantly increased in a dose-dependent manner for multiparous cows (4.1, 6.8, and 11.0%). Results demonstrated that bST administered in a prolonged-release formulation was efficacious in enhancing milk production and feed efficiency.     

Postparturient metabolic and production responses in cows previously exposed to long-term treatment with somatotropin.

Postparturient metabolic and production responses were studied for 85 multiparous cows consisting of controls and animals that had been previously exposed to long-term treatment with bST. Older cows previously exposed to bST at high doses (51.6 mg/d) had lower milk yields than controls. However, there were no significant differences compared with controls in milk yield for lower dose (17.2 mg/d) older cows or parity 2 cow groups. The bST-treated groups had higher postpartum DMI, lower serum FFA, lower serum beta-hydroxybutyrate levels, and higher serum glucose than controls. Some bST-exposed groups had lower milk fat but higher milk protein levels. All bST-treated groups had significantly lower ratios of C18 to C4 to 10 milk fatty acids. Control cows of both parity groups were in higher body condition and weighed more than bST-treated cows prior to calving. The differences in postpartum metabolism may be attributed to differences in body composition resulting from bST treatment in the prior lactation, because use of body condition score prior to calving as a covariate did not substantially alter responses. The control cows probably had greater reserves of mobilizable lipid. These contentions are supported by changes in milk composition for bST-treated cows, which were consistent with animals of greater appetite, mobilizing less lipid. The bST-treated cows were probably more energetically efficient milk producers because they produced milk from feed rather than from mobilization of tissue stores. These data suggest that bST use in a prior lactation may have potential benefit in reducing risk of metabolic disorders associated with lipid mobilization in the postparturient period.     

Genetic relationships between body condition score and reproduction traits in Canadian Holstein and Ayrshire first-parity cows

The objective of this study was to investigate the genetic relationship between body condition score (BCS) and reproduction traits for first-parity Canadian Ayrshire and Holstein cows. Body condition scores were collected by field staff several times over the lactation in herds from Québec, and reproduction records (including both fertility and calving traits) were extracted from the official database used for the Canadian genetic evaluation of those herds. For each breed, six 2-trait animal models were run; they included random regressions that allowed the estimation of genetic correlations between BCS over the lactation and reproduction traits that are measured as a single lactation record. Analyses were undertaken on data from 108 Ayrshire herds and 342 Holstein herds. Average daily heritabilities of BCS were close to 0.13 for both breeds; these relatively low estimates might be explained by the high variability among herds and BCS evaluators. Genetic correlations between BCS and interval fertility traits (days from calving to first service, days from first service to conception, and days open) were negative and ranged between −0.77 and −0.58 for Ayrshire and between −0.31 and −0.03 for Holstein. Genetic correlations between BCS and 56-d nonreturn rate at first insemination were positive and moderate. The trends of these genetic correlations over the lactation suggest that a genetically low BCS in early lactation would increase the number of days that the primiparous cow was not pregnant and would decrease the chances of the primiparous cow to conceive at first service. Genetic correlations between BCS and calving traits were generally the strongest at calving and decreased with increasing days in milk. The correlation between BCS at calving and maternal calving ease was 0.21 for Holstein and 0.31 for Ayrshire and emphasized the relationship between fat cows around calving and dystocia. Genetic correlations between calving traits and BCS during the subsequent lactation were moderate and favorable, indicating that primiparous cows with a genetically high BCS over the lactation would have a greater chance of producing a calf that survived (maternal calf survival) and would transmit the genes that allowed the calf to be born more easily (maternal calving ease) and to survive (direct calving ease).     

Metabolic and production responses to dietary protein and exogenous somatotropin in late gestation dairy cows.

Forty-three multiparous Holstein cows were used in a completely randomized design to evaluate the effects of protein supplementation and the use of bovine somatotropin (bST; Posilac, Monsanto Co., St. Louis, MO) in late gestation on animal metabolism and productivity in the periparturient period. Treatments were initiated 28 d prior to expected calving date and continued through parturition. Diets contained either 13.3 or 17.8% crude protein and were formulated to be similar in profile of protein fractions. Within each dietary treatment, cows were assigned to receive either 0 or 500 mg of sustained released bST once every 14 d until parturition. Following parturition, all cows were subjected to the same management and dietary treatments, and production measurements were followed until 42 d in milk. The use of bST increased plasma glucose and decreased plasma nonesterified fatty acids and beta-hydroxybutyrate prior to calving. Despite these changes in metabolism, bST did not affect concentrations of fat and triglyceride in the liver prepartum or postpartum. Feeding the 17.8% protein diet failed to stimulate glucose metabolism and tended to elevate plasma beta-hydroxybutyrate in late gestation. Cows treated with bST produced 3.3 kg/d more milk than did controls across the first 42 d of lactation; the difference was 4.6 kg/d in wk 6 of lactation. The use of bST in late gestation has considerable promise to alter cow metabolism positively. The results of these and other possible periparturient responses to somatotropin may increase milk production in early lactation.     

Responses of Holstein cows to a low dose of somatotropin (bST) prepartum and postpartum

Objectives were to evaluate the effects of a low dose of bovine somatotropin (bST) injected prepartum and postpartum on body condition score (BCS), body weight (BW), and milk yield (MY) in cows as well as somatotropin insulin, insulin-like growth factor-I (IGF-I), glucose, and nonesterified fatty acids (NEFA) in plasma. Holstein cows nearing second or later parities were assigned randomly to control (CON = 98) or bST-treated (TRT = 95) groups. Biweekly injections of bST began 21 +/- 3 d before expected calving and continued through 42 d postpartum (CON vs. TRT; 0 vs. 10.2 mg of bST/ d). From 42 to 100 d postpartum, no cows received bST. During yr 1, somatotropin, IGF-I, insulin, NEFA, and glucose were measured in plasma samples from 82 cows. During yr 2, effects of bST on BCS and BW of 111 cows were evaluated, but no blood samples were collected. Milk yields through 100 d of all 193 cows were analyzed. Prepartum treatment with bST resulted in greater prepartum plasma concentrations of somatotropin, insulin, and numerically greater NEFA but did not affect glucose or IGF-I. Postpartum bST increased mean plasma concentrations of somatotropin and NEFA, but not INS, IGF-I, or glucose. Mean BCS of cows did not differ prepartum, around parturition, or postpartum. Although mean BW did not differ prepartum or around calving, cows receiving bST maintained greater BW postpartum. Cows receiving bST tended to have higher MY (6.6%) in the first 60 d of lactation, but differences did not persist through 100 d, including approximately 40 d when no cows received bST. Number of cows that were culled due to health (CON = 3 vs. TRT = 2) or died (CON = 3 vs. TRT = 1) were not affected by treatment. Low doses of bST in the transition period resulted in higher postpartum BW, quicker recovery of body condition during lactation, and significantly more milk during treatment.     

Associations between herd characteristics and reproductive efficiency in dairy herds

Dairy herds worldwide are experiencing a decline in reproductive efficiency at the same time as management methods are changing. This study aimed to investigate the extent to which herd-level characteristics were associated with reproductive performance. Data from herds using artificial insemination (AI) in the Swedish Official Milk Recording Scheme that had more than 45 cows were included in the study (total of 2,728 herds). Reproductive performance was measured as the average for each herd for the calving interval, calving to first AI interval, calving to last AI interval, number of AI per animal submitted for AI, and culling attributed to reproductive problems. Herds with mainly Swedish Holstein cows had longer calving intervals, calving to first AI, and calving to last AI compared with herds with mainly Swedish Red and White cows. Large herds had shorter calving to first AI but a greater number of AI than small herds, whereas small herds had greater culling attributed to reproductive problems than large herds. Low-yielding herds had longer calving intervals, calving to first AI, and calving to last AI and had greater culling attributed to reproductive problems than high-yielding herds, whereas herds with high milk yields had a greater number of AI than low-yielding herds. Herds with automatic milking systems had shorter calving intervals, calving to first AI, and calving to last AI and had lesser odds for culling attributed to reproductive problems when compared with herds with ordinary pipeline milking systems. Herds that used Advanced Feed Advisory Services had shorter calving to first AI but a greater number of AI and greater culling attributed to reproductive problems. Herds using TMR had longer calving intervals and calving to last AI than herds that did not. Herds with tie stalls had longer calving intervals, calving to first AI, and calving to last AI, and organic herds had shorter calving intervals, calving to first AI, and calving to last AI compared with conventional herds. We found that herds with do-it-yourself inseminations had longer calving intervals and calving to first AI. Our study showed numerous associations between herd characteristics and reproductive performance. When allocating advisory service resources to improve reproductive performance, the focus should be on herd characteristics that are easy to influence, such as TMR and do-it-yourself inseminations.     

Effects of sustained release bovine somatotropin (sometribove) on animal health in commercial dairy herds

The health of dairy cows given bovine somatotropin (bST) for one lactation was evaluated in 28 commercial herds located in four regions of the United States. At least six herds were in a region and at least one herd/region contained fewer than 60 cows. Cows (n = 1213) were assigned randomly to control or bST groups and were treated beginning in wk 9 to 10 of lactation and every 14 d until dry-off or d 400 of lactation. Management was according to site practices. Cows were observed for health-related signs by farm personnel daily and by the herd veterinarian biweekly. Average 305-d test-day milk yields were 932 kg greater for bST-treated cows. Pregnancy rates, days open, twinning, cystic ovaries, or abortions were unaffected by treatments. Supplementation of cows with bST had no effect on total mastitis cases, total days of mastitis, duration of mastitis, or the odds ratio of a cow to develop mastitis. Cows supplemented with bST used more medications for health events other than mastitis. This usage was associated primarily with treatments for disorders of the foot and hock. Supplemented cows had a slight increase in foot disorders. There was no effect of supplementation with bST on culling from the herd or removal from study. Overall, the results confirm that label directions for bST are adequate for safe use under field conditions. All clinical signs observed in this study occur normally in dairy herds and were managed in cows supplemented with bST.     

Responses by lactating cows in commercial dairy herds to recombinant bovine somatotropin

Cows (890) in 15 US herds were assigned randomly in equal numbers to control or bST injections (500 mg in a prolonged-release form every 14 d for 12 wk) within three stages of lactation (57 to 100, 101 to 140, and 141 to 189 d postpartum) and two parity groups (primiparous and multiparous). Yield and milk composition were monitored 1 d/wk for 16 wk including 2 wk pretreatment and 2 wk posttreatment. Increases in milk and FCM due to bST injections were less at 57 to 100 d than at 101 to 189 d postpartum (milk 3.6 vs. 5.5; FCM 3.9 vs. 6.1 kg/d per cow), and increases in milk and FCM were more for multiparous than for primiparous cows (milk 5.5 vs. 4.2; FCM 6.0 vs. 4.7 kg/d cow). Temporarily, concentration of milk fat increased and protein decreased; later, concentrations for control and injected cows were similar. Postinjection milk fat concentration decreased, but milk protein concentration increased temporarily. The net increase in milk (and FCM) varied significantly among herds from 2.9 to 7.6 kg/d per cow (mean, 4.9 kg). Responses in FCM were similar over a wide range of pretreatment yields. A great variety of feed ingredients were fed as total mixed rations, and nutrient concentrations varied greatly. The SCC were similar before, during, and after treatment, but increase in FCM of injected cows exhibited a negative correlation with pretreatment SCC. Changes in body condition score of sometribove-injected cows varied among herds (.25 to -.45) and averaged -.02 compared with .07 for controls. There was no pattern in incidence of mastitis during sometribove injections.     

Conception rates and calving intervals after prostaglandin F2 alpha or prebreeding progesterone in dairy cows

Two experiments were performed in two different herds to determine if utilizing prostaglandin F 2 alpha to induce estrus for first services would be effective in reducing the duration and variability of calving intervals. In Experiment 1, cows were assigned randomly as controls (n = 217) to be inseminated as they were detected in estrus (beginning d 42 to 53 postpartum depending on replicate) or treated with prostaglandin F2 alpha (n = 185). In Experiment 2, the same treatments were utilized, except control cows (n = 124) were inseminated at their first detected estrus after d 40 postpartum, and treated cows received either one injection of prostaglandin F2 alpha between d 54 and 63 (n = 116) or were given progesterone (via a progesterone-releasing intravaginal device) for 7 d, with the device removed 24 h after prostaglandin F2 alpha (n = 116). More cows were inseminated and pregnancy rates were higher within 5 d after treatment with prostaglandin F2 alpha, and interval from prostaglandin F2 alpha to first service was reduced compared with that of control cows. Duration and variation of calving intervals were unaffected in either experiment, despite the fact the elective waiting period was 6 to 23 d longer for treated cows than for controls. Prebreeding treatment with progesterone failed to improve conception rates, but the efficiency of estrous expression increased from 54% in prostaglandin F2 alpha-treated cows to 71% in those cows also receiving prebreeding progesterone. We conclude that prostaglandin F2 alpha was ineffective in improving reproductive performance of these herds under good herd management. However, prostaglandin F2 alpha offers the convenience of inseminating small groups of cows, controlling when breedings occur during the work week, and prolonging the elective waiting period without extending the calving interval.     

Factors affecting response of cows to biweekly injections of sometribove.

Seventy-eight lactating Holstein cows (18 primiparous and 60 multiparous) were used to study certain factors affecting response in milk yields to biweekly injections of bST. Cows were intramuscularly injected with placebo or with 500 mg of bST every 14 d for 36 wk beginning 60 d postpartum. Primiparous cows responded less to bST than did multiparous cows. Cows were separated into three yield groups within each treatment based on pretreatment yield: low (27.0 kg/d), medium (32.0 kg/d), and high (39.0 kg/d). Response of low yielding cows to bST was numerically greater than that of medium or high yielding cows, but there was no significant interaction between treatment and pretreatment milk yield. Individual cow index for milk yield was used as a measure of genetic potential of cows, which were divided into two index groups: high cow index (greater than -23 kg) and low cow index (less than -23 kg). Cows in the high index group showed significantly higher milk yields than the low index group during treatment, but treatment by cow index interaction was not significant, suggesting that cows of widely ranging genetic potential respond similarly to bST. Response of cows to bST in mid to late lactation was slightly greater than in early lactation (15.9 and 10.6% vs. 17.8%, respectively), but no significant interaction of treatment by days postpartum was noted. Finally, even though cows treated with bST exhibited slightly higher rectal temperatures during the hot summer months, no significant difference in milk yield response to bST was noted during periods of moderate versus high ambient temperatures.     

Effects of whole cottonseed diet and recombinant bovine somatotropin on ovarian follicles in lactating dairy cows

The effects of whole cottonseed (WCS) in the diet and the administration of bovine somatotropin (bST) on ovarian follicular dynamics and plasma progesterone (P4) concentrations were examined in cows during a period of synchronized follicular growth. Lactating Holstein cows (n = 28) were randomly assigned to treatments in a 2 x 2 factorial arrangement. Diets consisted of WCS (15% of dry matter) or no WCS, and bST at a dose of 0 or 208 mg/14 d. Dietary treatments began within 24 h of calving and bST treatments began within 7 d postpartum. Cows received GnRH at 65 +/- 3 d postpartum (d 0), PGF2alpha, (d 7), a second dose of GnRH (d 9), and were inseminated 16 h later (d 10). Ovarian changes were monitored daily by ultrasonography from d 0 to 9. On d 9,93% of cows had a preovulatory follicle and 86% ovulated. For Class 2 (6 to 9 mm) follicles, a diet x bST interaction was detected, with bST stimulating Class 2 follicles in cows fed WCS, but not in cows on the control diet. Neither diet nor bST affected numbers of Class 1 (2 to 5 mm) or Class 3 (> or = 10 mm) follicles or sizes of the subordinate and dominant follicles. During the luteal phase of the cycle, lactating cows fed WCS tended to have elevated concentrations of plasma P4, whereas bST was without effect. Plasma concentrations of high-density lipoprotein cholesterol were increased in cows fed WCS. Number and diameter of corpora lutea did not differ among treatments.     

Overall efficacy of chronically administered recombinant bovine somatotropin to lactating dairy cows

Recombinant bST at daily dosages of 0, 10.3, 20.6, and 41.2 mg/d were injected for 266 d into 8, 10, 9, and 9 Holstein cows, respectively. Treatment effects of recombinant bST were assessed for milk production traits, BW, blood components, and health and reproductive variables. Data reported compare controls to all bST-treated cows. There was an average increase of 18% in 3.5% FCM for bST versus control cows. This increase resulted in enhanced feed efficiency for bST cows, as their DM intakes were not elevated above those of the control cows. Recovery of BW was similar between control and bST groups. Milk composition was unaffected except for a slight decrease in protein percentage during the first 9 wk of treatment, and an elevated SCC between wk 19 and 28. Blood parameters were not different between control and bST cows, except for hematocrit, which decreased with bST treatment. The only health and reproductive parameters affected by bST were mastitis and days open, which were increased in the highest dosage groups.     

Response to recombinant bovine somatotropin in dairy cows with different genetic merit for milk production

Thirty-nine multiparous cows obtained from two genetic lines were utilized to determine the effect of genetic merit on lactation response to long-term administration of recombinant bST. Cow index ranged from -70 to 456 (mean = 183) and -494 to -88 (mean = -288) kg milk for high and low genetic groups, respectively. Cows were blocked by calving date and randomly assigned to treatment within genetic group. Treatments were 0, 10.3, 20.6, and 30.9 mg somatotropin injected daily from wk 14 through 44 postpartum. Cows were fed one of two total mixed rations. Diet 1 (NE1 = 1.65 Mcal/kg, CP = 18%, and ADF = 22%) was fed from start of lactation to at least 4 wk after initiation of treatment. Cows were switched to diet 2 (NE1 = 1.56 Mcal/kg, CP = 16%, and ADF = 27%) when milk output fell below 25 kg/d. Forty-four week lactation yields were 9800 and 9447 kg milk; 364 and 354 kg fat; and 322 and 309 kg protein for high and low genetic groups, respectively. Milk, milk fat, or protein yield due to somatotropin did not differ between genetic groups. Increasing dosage of bST increased milk, 4% FCM, fat, and protein yields in a linear fashion. Percentages of fat and protein of milk were similar for all treatment groups. Body weight changes were not significantly different among treatments, but condition score changes decreased linearly with increasing dose of bST. Long-term treatment with recombinant bST had no apparent effect on incidence of health problems or reproduction.     

Effects of nutrition on the fertility of lactating dairy cattle

This meta-analysis of 39 experiments containing 118 treatments explored the effects of diet interventions in early lactation on the proportion of dairy cows pregnant to artificial insemination (AI; pregnancy to AI) and on calving to pregnancy interval. It also identified factors that may explain variation in these responses. The objectives were to identify effects of diet on reproduction, rather than differences between specific dietary interventions. The examination of calving to pregnancy interval used the more traditional method of analyzing differences between a treatment and the reference treatment used for comparison within a given experiment. The systematic review identified fewer experiments (n = 39) than had been expected. Four different multivariable models including the random effect of experiment were used to examine the effects of CPM-Dairy (version 3.08) estimated diet and production variables on proportion pregnant to AI. These models examined (1) output of products, (2) balance or duodenal availability of nutrients, (3) intake of nutrients, or (4) percentage of nutrients in the diet. The multivariable models identified positive associations between estimated increased fatty acid intake [incidence rate ratio (IRR) = 1.0003 ± 0.0001g/d; ±standard error], starch intake (IRR = 1.061 ± 0.029 kg/d), metabolizable energy balance (IRR = 1.004 ± 0.002 MJ/d), and duodenal C14:0 (IRR = 1.008 ± 0.004 g/d) availability with the proportion of cows pregnant to AI, whereas rapidly fermentable sugar intake (IRR = 0.813 ± 0.054 kg/d), percentage of sugar in the diet (IRR = 0.960 ± 0.015%), and milk protein yield (IRR 0.922 ± 0.022 g/100 g per day) were associated with a reduced proportion of cows pregnant to AI. There was no multivariable model developed to assess variables associated with calving to pregnancy interval but, univariably, increased metabolizable energy balance was associated with a shorter calving to pregnancy interval whereas increased milk production was associated with longer time to pregnancy. Increased intake of some AA, particularly threonine and lysine, were associated with a longer calving to pregnancy interval. It is clear nutritional management around calving can influence reproductive success. The importance of dietary fats and increased energy and protein balances in early lactation for improved fertility outcomes is supported and suggests that starch and sugars may have different effects on the proportion of cows that are pregnant to AI. This work also highlighted a need for further focused field studies exploring the roles of specific fatty acids, AA, phosphorus, and carbohydrates on reproduction.